Atea Pharmaceuticals, Inc.

Ticker: AVIR
Current Price: $4.30
% Daily Change: 2.14%
Volume (1,000s): 302.65
Average Volume (1,000s): 327.71
Market Cap (M): $345.31
1/2/2024 Price: $3.21
Change Since Inception: 33.96%
Contact Information

Atea Pharmaceuticals, Inc.
225 Franklin Street
Suite 2100
Boston, MA 02110
United States

About Atea Pharmaceuticals, Inc.

Leveraging the power of our medicinal chemistry expertise and discovery capabilities, we are focused on discovering, optimizing, and rapidly advancing novel drug candidates for viral targets such as SARS-CoV-2 and HCV.

Our medicinal chemistry and virology expertise, bolstered by our collective experience in drug development, is enabling us to pioneer new advancements in antiviral science.

Atea and its employees believe in giving back to the community and work to achieve this goal on a local and global level. We are proud to contribute to local programs that help children and families in Massachusetts, provide sponsorship resources to conferences and academics in our field of research and support organizations that provide medical and humanitarian aid.

At Atea, we believe that our long-term success and ability to deliver medicines to patients requires a diverse, equitable and inclusive workforce. We are committed to creating an environment where all Atea employees are enabled to achieve their full potential. By providing the opportunity for employees to bring their unique differences and perspectives to work, our business grows stronger with original thinking.

We promote an environment of diversity, equity and inclusiveness at Atea, regardless of race, gender, sexual orientation, religion, ethnicity, national origin, physical disability, or age.

Market Data

News

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup